Literature DB >> 7671315

Modulation of MHC class II expression in human cells by dexamethasone.

L M Schwiebert1, R P Schleimer, S F Radka, S J Ono.   

Abstract

The effect of dexamethasone on human MHC class II expression was examined on various cell types including lymphocytes, monocytes, and epithelial cells. Dexamethasone decreased the surface expression of HLA-DR and -DP, but not HLA-DQ, on lymphocytic cell lines that constitutively express these molecules. In addition, dexamethasome down-regulated the mRNA levels of HLA-DRA, but not of HLA-DQB, in Jijoye cells, a human lymphoblastic cell line. Similarly, dexamethasone decreased HLA-DR expression on epithelial and monocytic cell lines that express HLA-DR upon IFN-gamma treatment. In total, these results suggest that dexamethasone inhibits both constitutive and IFN-gamma-inducible MHC class II expression in several cell types. Moreover, these results indicate that the inhibitory effect of dexamethasone on MHC class II expression is selective for HLA-DR and -DP but not HLA-DQ. Possible mechanisms of dexamethasone-mediated regulation of MHC class II expression are discussed.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7671315     DOI: 10.1006/cimm.1995.1181

Source DB:  PubMed          Journal:  Cell Immunol        ISSN: 0008-8749            Impact factor:   4.868


  17 in total

1.  Glucocorticoid-regulated genes in eosinophilic esophagitis: a role for FKBP51.

Authors:  Julie M Caldwell; Carine Blanchard; Margaret H Collins; Philip E Putnam; Ajay Kaul; Seema S Aceves; Catherine A Bouska; Marc E Rothenberg
Journal:  J Allergy Clin Immunol       Date:  2010-04       Impact factor: 10.793

2.  Expanded CD14+ CD16+ monocyte subpopulation in patients with acute and chronic infections undergoing hemodialysis.

Authors:  W A Nockher; J E Scherberich
Journal:  Infect Immun       Date:  1998-06       Impact factor: 3.441

3.  Postoperative immunosuppression markers and the occurrence of sepsis in patients with benign and malignant disease.

Authors:  Tamara Alkhamis; Dubravka Ivić; Jasenka Wagner; Josip Ivić; Blaženka Dobrošević; Ivana Turina; Kristina Kralik; Jerko Barbić
Journal:  Wien Klin Wochenschr       Date:  2014-10-03       Impact factor: 1.704

4.  Putative biological mechanisms for the association between early life adversity and the subsequent development of PTSD.

Authors:  Rachel Yehuda; Janine D Flory; Laura C Pratchett; Joseph Buxbaum; Marcus Ising; Florian Holsboer
Journal:  Psychopharmacology (Berl)       Date:  2010-08-13       Impact factor: 4.530

5.  Persisting low monocyte human leukocyte antigen-DR expression predicts mortality in septic shock.

Authors:  Guillaume Monneret; Alain Lepape; Nicolas Voirin; Julien Bohé; Fabienne Venet; Anne-Lise Debard; Hélène Thizy; Jacques Bienvenu; François Gueyffier; Philippe Vanhems
Journal:  Intensive Care Med       Date:  2006-06-02       Impact factor: 17.440

6.  Primary immune response to keyhole limpet haemocyanin following trauma in relation to low plasma glutamine.

Authors:  P G Boelens; J C M Fonk; A P J Houdijk; R J Scheper; H J T H M Haarman; S Meijer; P A M Van Leeuwen; B M E von Blomberg-van der Flier
Journal:  Clin Exp Immunol       Date:  2004-05       Impact factor: 4.330

Review 7.  Epithelial cells as immune effector cells: the role of CD40.

Authors:  Kari Dugger; Thomas W Lowder; Torry A Tucker; Lisa M Schwiebert
Journal:  Semin Immunol       Date:  2009-07-22       Impact factor: 11.130

Review 8.  Monitoring immune dysfunctions in the septic patient: a new skin for the old ceremony.

Authors:  Guillaume Monneret; Fabienne Venet; Alexandre Pachot; Alain Lepape
Journal:  Mol Med       Date:  2008 Jan-Feb       Impact factor: 6.354

9.  Involvement of CREB binding protein in expression of major histocompatibility complex class II genes via interaction with the class II transactivator.

Authors:  A Kretsovali; T Agalioti; C Spilianakis; E Tzortzakaki; M Merika; J Papamatheakis
Journal:  Mol Cell Biol       Date:  1998-11       Impact factor: 4.272

10.  Interactions between the class II transactivator and CREB binding protein increase transcription of major histocompatibility complex class II genes.

Authors:  J D Fontes; S Kanazawa; D Jean; B M Peterlin
Journal:  Mol Cell Biol       Date:  1999-01       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.